Review ArticleJournal of Pharmacology and PharmacotherapeuticsVol. 7 | Issue 3 | 2016 | pp. 127–132Open access
Phenytoin‑induced toxic epidermal necrolysis: Review and recommendations
- 1*
- 1 Department of Pharmacy Services, Clevevland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Osama M. Al‑Quteimat
Department of Pharmacy Services, Clevevland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Email: alquteo@clevelandclinicabudhabi.ae
Copyright: © 2016 Manuscript Technomedia LLP. This is an open access article.
- Published:
- Jan 1, 2016
- Received:
- Apr 7, 2016
- Accepted:
- Jul 15, 2016
How to cite
Al‑Quteimat, O. M. (2016). Phenytoin‑induced toxic epidermal necrolysis: Review and recommendations. Journal of Pharmacology and Pharmacotherapeutics, 7(3), 127–132. https://doi.org/10.4103/0976-500X.189662
Abstract
Toxic epidermal necrolysis (TEN) is a serious, life‑threatening skin reaction characterized by severe exfoliation and destruction of the epidermis of the skin. In most TEN cases, drugs are believed to be the causative agent; antipsychotics, antiepileptics, and other medications such as sulfonamides are among the most common causes of drug‑induced TEN. Phenytoin, a commonly prescribed medication for seizure, was found to cause TEN. Evidence‑based treatment guidelines are lacking, so the best strategy is to identify and avoid potential risk factors and to provide intensive supportive care. The aim of this literature review is to focus on phenytoin‑induced TEN, to explore the risk factors, and to highlight the possible treatment options once phenytoin‑induced TEN is confirmed.
Keywords
Subject
Article metadata
| Title | Phenytoin‑induced toxic epidermal necrolysis: Review and recommendations |
|---|---|
| Authors | Osama M. Al‑Quteimat |
| Affiliations | Department of Pharmacy Services, Clevevland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates. |
| Corresponding author | alquteo@clevelandclinicabudhabi.ae |
| Journal | Journal of Pharmacology and Pharmacotherapeutics |
| Volume / Issue | Vol. 7, Issue 3 (2016) |
Also in this issue
- The three Rs of written assessment: The JIPMER experiencepp. 115–116
- What failed BIA 10–2474 Phase I clinical trial? Global speculations and recommendations for future Phase I trialspp. 120–121
- Deprescription: The prescription metabolismpp. 133–137
- Cold sodium chloride solution 0.9% and infrared thermography can be an alternative to radiopaque contrast agents in phlebographypp. 138–9
- Cisplatin resistance reversal by disulfiram and caffeinepp. 139–141
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026